Name | Photograph | Designation | Educational Qualifications | Registration Number |
---|---|---|---|---|
Prof. (Dr) Saswati Halder | Professor and Head | MBBS, MD(DVL) | WBMC 48939 | |
Dr. Jayanta Kumar Barua | Associate professor | MBBS, MD(DVL) | WBMC 55505 | |
Dr. Projna Biswas | Assistant professor | MBBS, MD(DVL) | WBMC 64962 | |
Dr. Gourab Roy | Assistant professor | MBBS, MD(DVL) | WBMC 67973 | |
Dr. Avik Panigrahi | Demonstrator | MBBS, MD(DVL) | WBMC 66387 | |
Dr. Nibir Biswas | RMO cum Clinical Tutor | MBBS, PhD | WBMC 47299 | |
Dr. Partha Pratim Sarkar | RMO cum Clinical Tutor | MBBS | WBMC 72373 |
Name | Designation |
---|---|
Dr. Prabal Samanta | Senior Resident |
Dr. Rik Goswami | Senior Resident |
Dr. Pratik Dey | Senior Resident |
Total | 2,32, 564 |
---|---|
New patients | 1,96,558 |
Old patients | 36,006 |
Total leprosy case attended | 1635 |
New Leprosy cases | 195 |
Procedure | Number |
---|---|
Biopsy | 248 |
Electro Cautery | 116 |
Radio Frequency | 93 |
Chemical Frequency | 350 |
Intra Lesional Injecton | 415 |
Iontophoresis | 12 |
PRP | 84 |
Vitiligo Surgery | 5 |
Phototherapy | 108 |
Investigator | Title of the Project |
---|---|
Dr. Saswati Halder (PI), Dr. Prabal Samanta (Co-PI) | A randomized open label, parallel group study to evaluate the safety to evaluate the safety and efficacy of Abrocitinib 100 mg and 200 mg tablets in participants aged 12 years and older with moderate to severe atopic dermatitis in India. |
Dr. Saswati Halder (PI), Dr. Prabal Samanta (Co-PI) | A randomized , double blind , placebo controlled , multicenter dose ranging trial to evaluate the safety of ASLAN004 in adult patient with moderate to severe atopic dermatitis. |